ArticleLung Cancer (Auckland, N.Z.)2026

HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib - A Case Report.

Misako Nagasaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.